Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 2
2010 1
2011 3
2012 4
2013 8
2014 3
2015 9
2016 5
2017 4
2018 7
2019 8
2020 7
2021 7
2022 9
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Secondary Publication: Proposal for Points of Consideration for Pluripotent Stem Cell Culture.
Aoi T, Asaka I, Akutsu H, Ito Y, Kataoka K, Kanda Y, Kojima H, Sekino Y, Suemori H, Nakagawa M, Nakamura K, Nakamura Y, Fujii M, Furue M, Yamazaki D; Japanese Working Group for Consideration of Good Cell Culture Practice. Aoi T, et al. Among authors: kojima h. In Vitro Cell Dev Biol Anim. 2024 Mar 12. doi: 10.1007/s11626-024-00863-w. Online ahead of print. In Vitro Cell Dev Biol Anim. 2024. PMID: 38472720
The inter-laboratory validation study of EpiSensA for predicting skin sensitization potential.
Mizumachi H, Watanabe M, Ikezumi M, Kajiwara M, Yasuda M, Mizuno M, Imai N, Sakuma M, Shibata M, Watanabe SI, Motoyama J, Basketter D, Eskes C, Hoffmann S, Lehmann DM, Ashikaga T, Sozu T, Takeyoshi M, Suzuki S, Miyazawa M, Kojima H. Mizumachi H, et al. Among authors: kojima h. J Appl Toxicol. 2024 Apr;44(4):510-525. doi: 10.1002/jat.4559. Epub 2023 Oct 28. J Appl Toxicol. 2024. PMID: 37897225
International regulatory uses of acute systemic toxicity data and integration of new approach methodologies.
Strickland J, Haugabrooks E, Allen DG, Balottin LB, Hirabayashi Y, Kleinstreuer NC, Kojima H, Nishizawa C, Prieto P, Ratzlaff DE, Jeong J, Lee J, Yang Y, Lin P, Sullivan K, Casey W. Strickland J, et al. Among authors: kojima h. Crit Rev Toxicol. 2023 Aug;53(7):385-411. doi: 10.1080/10408444.2023.2240852. Epub 2023 Aug 30. Crit Rev Toxicol. 2023. PMID: 37646804 Review.
A step-by-step approach for assessing acute oral toxicity without animal testing for additives of quasi-drugs and cosmetic ingredients.
Kojima H, Nakada T, Yagami A, Todo H, Nishimura J, Yagi M, Yamamoto K, Sugiyama M, Ikarashi Y, Sakaguchi H, Yamaguchi M, Hirota M, Aizawa S, Nakagawa S, Hagino S, Hatao M. Kojima H, et al. Curr Res Toxicol. 2022 Dec 23;4:100100. doi: 10.1016/j.crtox.2022.100100. eCollection 2023. Curr Res Toxicol. 2022. PMID: 36619289 Free PMC article. Review.
Validation study for in vitro skin irritation test using reconstructed human skin equivalents constructed by layer-by-layer cell coating technology.
Akagi T, Yamada T, Miyazaki H, Taguchi H, Ikeda H, Katoh M, Mura S, Couvreur P, Chetprayoon P, Maniratanachote R, Yoshida H, Ajiro H, Hashimoto K, Ashikaga T, Kojima H, Akashi M. Akagi T, et al. Among authors: kojima h. J Appl Toxicol. 2023 Jun;43(6):874-886. doi: 10.1002/jat.4431. Epub 2023 Feb 15. J Appl Toxicol. 2023. PMID: 36594553
An international validation study of the interleukin-2 luciferase leukocyte toxicity test (IL-2 Luc LTT) to evaluate potential immunosuppressive chemicals and its performance after use with the interleukin-2 luciferase assay (IL-2 Luc assay).
Yutaka K, Rie Y, Iwaki T, Fujimura C, Ohmiya Y, Nakajima Y, Omori T, Corsini E, Inoue T, Rogen EL, Kojima H, Aiba S. Yutaka K, et al. Among authors: kojima h. Toxicol In Vitro. 2023 Apr;88:105535. doi: 10.1016/j.tiv.2022.105535. Epub 2022 Dec 13. Toxicol In Vitro. 2023. PMID: 36526088 Clinical Trial.
77 results